LASAPharmaceuticals

Lassonde Industries IncQuarterly Results & Earnings

5.67
-12.87%
Profit Growth YoY-93.50%Latest quarter
Sales Growth YoY-92.23%Latest quarter
Sales CAGR 5Y-3.16%5 year compound
Profit CAGR 5Y-24.86%5 year compound
📋

Quarterly Performance

YoY Profit Growth-93.50%
🔴 Significant decline
YoY Sales Growth-92.23%
🔴 Significant decline
OPM 5Y Average
Operating profit margin
9.19%
EPS Growth 5Y
-27.93%
Interest Coverage
Higher = safer debt servicing
-10.23
ROE
1.01%
ROCE
-1.00%
💡

Growth Analysis

Lassonde Industries Inc reported YoY profit growth of -93.50% and revenue growth of -92.23% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -3.16% and profits at -24.86% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.